594.00GBp-6.60%Mkt Cap: 43.90M $P/E: —Today
Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer in the United Kingdom and the United States. The company'…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap43.90M $
Enterprise Value42.16M $
Revenue (TTM)—
Gross Profit-1.01M $
Net Income (TTM)-10.61M $
Revenue/Share—
Last Price594.00 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees16
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.72
EV/Revenue—
P/S—
P/B32.26
EPS (TTM)-1.71
EPS (Forward)—
52W Range
156.0027% of range1800.00
52W High1800.00 GBp
52W Low156.00 GBp
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-816.50%
ROA-233.73%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.75M $
CapEx (TTM)4.26K $
FCF Margin—
FCF Yield-8.24%
Net Debt454.15K $
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity1.68
Current Ratio1.38
Quick Ratio1.09
Book Value/Sh0.1980 GBp
Cash/Share0.2630 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:400
Split DateDec 13, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.80M
Float4.65M
Insiders29.43%
Institutions0.41%
Technical
SMA 50726.21 (-18.2%)
SMA 200775.17 (-23.4%)
Beta1.50
S&P 52W Chg18.16%
Avg Vol (30d)9.88K
Avg Vol (10d)8.91K
Technical Indicators
RSI (14)43.1
MACD-30.6093
MACD Signal-31.8104
MACD Hist.+1.2010
BB Upper743.48 GBp
BB Middle655.70 GBp
BB Lower567.92 GBp
BB Width26.77%
ATR (14)62.82 GBp
Vol Ratio (20d)1.27x